Countdown to BIO 2000 Press Can Register Now!

  • Contact: Charles Craig
    Tiesha Higgins
    202-962-9200
  • Recommend
  • Tweet
  • Print
  • Email

Washington, D.C. (January 11, 2000) The Biotechnology Industry Organization (BIO) will host its 14th International Biotechnology Meeting and Exhibition two months earlier than usual this year. BIO 2000 activities, scheduled for March 26-30, will take place in Boston at the Hynes Convention Center.

Under the theme Biotech Works, BIO 2000 is expected to attract 7,000 industry executives, researchers, investors, biotech leaders and news media, topping the 5,700 that attended last year’s meeting in Seattle.

More than 200 ninety-minute to three-hour symposiums and presentations are scheduled with titles like Pushing to the Immune System to Work, Transborder Deals, Antigen Delivery Technologies Directed at Cancer Immunotherapy, How Biotech Companies Can Raise Funds and Cell Based Technologies. The multi-faceted presentations will cover various issues in drug development, agricultural and industrial biotechnology, business development, clinical/regulatory issues, biotech financing, intellectual property, manufacturing/product development and more.

The scheduled speakers for BIO 2000 presentations include Senator Edward Kennedy (D-Mass. Herb Boyer of Genentech; William Haseltine, Ph.D. of Human Genome Sciences; Gordon Binder of Amgen; Henri Termeer of Genzyme Corporation; Randall W. Scott of Incyte Pharmaceuticals; Vaughn Kailian of COR Therapeutics; Iowa Governor Hon. Tom Vilsak; James Wilson from the Institute for Human Genome Therapy; and Joseph Scodari of Centocor.

The Biotechnology Industry Organization (BIO) represents more than 850 biotechnology companies, academic institutions and state biotechnology centers in 46 states and more than 26 nations. BIO members are involved in the research and development of health care, agricultural, industrial and environmental biotechnology products.

NOTE TO REPORTERS:

Registration for credentialed press is complimentary. Press can register on BIO’s website (www.bio.org/events/2000/bio2000.html) or, if internet access is not available, by calling BIO Communications Coordinator Tiesha Higgins at 202-962-9200. All reporters and writers must present media credentials for verification at the meeting. Freelancers must submit a letter from the editor of their publication.

A fully operational pressroom with computers and Internet access will be available. Additionally, briefings will be held each morning of the conference to highlight events and a press conference schedule will be posted on the website.

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.